H.R. 8358 · 119th Congress · Health
Breast Cancer Research Stamp Reauthorization Act of 2026
- IntroducedApr 16, 2026 Done
- CommitteeReferred to 3 committees Current stage
- House floorNot yet Not reached yet
- Senate floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
Full text
No CRS summary yet · 43 wordsH.R. 8358 · Introduced in House · Apr 16, 2026
This Act may be cited as the Breast Cancer Research Stamp Reauthorization Act of 2026 .
Section 414(h) of title 39, United States Code, is amended by striking 2027 and inserting 2037 .
Shown here because the text is under 500 words. Open on Congress.gov
Who lobbies on it
1 organization · 2 filings · Q2 2026–Q3 2026One square per quarter since introduction, oldest left. Filled = named it that quarter.
-
American College of Surgeons Professional Association
2 of 2 quarters
“…H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act H.R. 9693/S. 5672 - Patients First Act of 2026 H.R. 4583/S. 1552 - Living Donor Protection Act of 2026 H.R. 8271 - ICU Bed Act of 2026 H.R. 5265 - SAFE Ride Act (E-bike Safety) Military Readiness Office of Management and Budget (OMB) Rule Womens Health and…”
$90K lobbying spend in 2026 to date, all issuesQ3 2026 filing
Organizations that named H.R. 8358 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
2 actions · newest first- Apr 16, 2026Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Apr 16, 2026Introduced in House
What members said about it
-
Wasserman Schultz, Van Duyne Introduce the Breast Cancer Research Stamp Reauthorization Act
U.S. Representatives Debbie Wasserman Schultz (D-FL-25) and Beth Van Duyne (R-TX-24) introduced H.R. 8358 the Breast Cancer Research Stamp Reauthorization Act of 2026.
“I know what it's like to hear the dreaded words: 'you have breast cancer.' As a survivor, this fight is personal.”
-
Reps. Van Duyne and Wasserman Schultz introduce the Breast Cancer Research Stamp Reauthorization Act
U.S. Representatives Beth Van Duyne (R-TX-24) and Debbie Wasserman Schultz (D-FL-25) introduce H.R. 8358 the Breast Cancer Research Stamp Reauthorization Act of 2026.
“The Breast Cancer Research stamp program proves that small actions can make a big difference, raising nearly $100 million for lifesaving research over the past three decades.”